Jigar Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jigar Patel has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Arindam Chatterjee
Department of Cardiac Anesthesia, UN Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India
1 shared publication - Jamalpur Sravan Kumar
U. N. Mehta Institute of Cardiology and Research Center (Affiliated to BJ Medical College, Ahmedabad)
1 shared publication - Jignasha Chaudhary
U. N. Mehta Institute of Cardiology and Research Center (Affiliated to BJ Medical College, Ahmedabad)
1 shared publication Jyoti Masaniya
U. N. Mehta Institute of Cardiology and Research Center (Affiliated to BJ Medical College, Ahmedabad)
1 shared publication- Maruti Haranal
Department of Pediatric Cardiac Surgery, U N Mehta Institute of Cardiology and Research, Ahmedabad, India
1 shared publication - Rajendrakiran Brahmaroutu
U. N. Mehta Institute of Cardiology and Research Center (Affiliated to BJ Medical College, Ahmedabad)
1 shared publication
Latest Publications
- 21 July 2026
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
Comparison of Hemodynamic Effects of Milrinone, Levosimendan, and Dobutamine in Bidirectional Cavopulmonary Connection Surgery
Aim: The present study was done to compare the hemodynamic effects of 3 drugs—milrinone, levosimendan, and dobutamine in patients undergoing bidirectional cavopulmonary connection (BCPC) surgery. Materials and Methods: In this prospective observational study, a total of 75 patients between 3 months and 2 years of age who underwent BCPC were included. They were divided into milrinone (M), levosimendan (L), and dobutamine (D) groups. The primary aim was to compare the hemodynamic effects of 3 drugs in this subset of patients. Results: The mean age at surgery was 6.4 ± 2.6 months, with no significant differences in gender or weight among the groups. Perioperatively, heart rate and femoral venous pressure were significantly higher in the dobutamine group. Significant differences were noted in SpO 2 , Glenn pressures, Glenn pressure to mean arterial pressure (MAP) ratios, and near infrared spectroscopy values, with milrinone showing the most favorable outcomes, followed by levosimendan and dobutamine. Postoperative E/e′ values were significantly lower in all groups ( P < .001), with milrinone (4.7 ± 0.5) performing better than levosimendan (4.9 ± 0.9) and dobutamine (6.5 ± 1.2). Vasoactive inotropic scores decreased postoperatively in all groups but were significantly higher in the levosimendan group. No significant differences were observed in the duration of mechanical ventilation or intensive care unit stay. Notably, there were no mortalities during the study period. Conclusions: Milrinone offers superior hemodynamic benefits over levosimendan and dobutamine in patients undergoing BCPC using cardiopulmonary bypass. Its ability to significantly reduce Glenn pressure, lower the Glenn pressure to MAP ratio, and improve both systolic and diastolic functions makes it the preferred inotropic agent in this subset of patients.
- 21 July 2026
- Published by SAGE Publications in World Journal for Pediatric and Congenital Heart Surgery
Comparison of Hemodynamic Effects of Milrinone, Levosimendan, and Dobutamine in Bidirectional Cavopulmonary Connection Surgery
Aim: The present study was done to compare the hemodynamic effects of 3 drugs—milrinone, levosimendan, and dobutamine in patients undergoing bidirectional cavopulmonary connection (BCPC) surgery. Materials and Methods: In this prospective observational study, a total of 75 patients between 3 months and 2 years of age who underwent BCPC were included. They were divided into milrinone (M), levosimendan (L), and dobutamine (D) groups. The primary aim was to compare the hemodynamic effects of 3 drugs in this subset of patients. Results: The mean age at surgery was 6.4 ± 2.6 months, with no significant differences in gender or weight among the groups. Perioperatively, heart rate and femoral venous pressure were significantly higher in the dobutamine group. Significant differences were noted in SpO 2 , Glenn pressures, Glenn pressure to mean arterial pressure (MAP) ratios, and near infrared spectroscopy values, with milrinone showing the most favorable outcomes, followed by levosimendan and dobutamine. Postoperative E/e′ values were significantly lower in all groups ( P < .001), with milrinone (4.7 ± 0.5) performing better than levosimendan (4.9 ± 0.9) and dobutamine (6.5 ± 1.2). Vasoactive inotropic scores decreased postoperatively in all groups but were significantly higher in the levosimendan group. No significant differences were observed in the duration of mechanical ventilation or intensive care unit stay. Notably, there were no mortalities during the study period. Conclusions: Milrinone offers superior hemodynamic benefits over levosimendan and dobutamine in patients undergoing BCPC using cardiopulmonary bypass. Its ability to significantly reduce Glenn pressure, lower the Glenn pressure to MAP ratio, and improve both systolic and diastolic functions makes it the preferred inotropic agent in this subset of patients.